Review of pneumococcal conjugate vaccine in adults: implications on clinical development

This publication has 32 references indexed in Scilit:

• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
  New England Journal of Medicine, 2003
• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
  The Pediatric Infectious Disease Journal, 2002
• Hospitalized Community-acquired Pneumonia in the Elderly
  American Journal of Respiratory and Critical Care Medicine, 2002
• Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine Era
  JAMA, 2001
• Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
  The Lancet, 1998
• Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group
  Archives of internal medicine (1960), 1997
• Reactogenicity and Immunogenicity of a Protein-Conjugated Pneumococcal Oligosaccharide Vaccine in Older Adults
  The Journal of Infectious Diseases, 1996
• The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
  New England Journal of Medicine, 1991
• Efficacy of Pneumococcal Vaccine in High-Risk Patients
  New England Journal of Medicine, 1986